Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$1.4 - $2.09 $2,737 - $4,085
-1,955 Reduced 14.77%
11,278 $20,000
Q3 2023

Nov 13, 2023

BUY
$1.6 - $2.78 $21,172 - $36,787
13,233 New
13,233 $26,000
Q1 2023

May 11, 2023

SELL
$1.38 - $6.0 $54,090 - $235,176
-39,196 Reduced 54.67%
32,506 $130,000
Q4 2022

Feb 14, 2023

BUY
$1.14 - $2.0 $54,559 - $95,718
47,859 Added 200.73%
71,702 $95,000
Q2 2022

Aug 09, 2022

BUY
$2.02 - $4.53 $48,162 - $108,008
23,843 New
23,843 $57,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.